Eyam Health

Eyam is focused on the research and development of vaccines that are safe, efficacious and low dose. Subscribe to our newsletter:

[Eyam Health @EyamHealth]

Big news in the fight against drug-resistant #malaria:
 Eyam Health and @MedsforMalaria are co-developing a long-acting, AI-designed prevention shot—powered by Gemini—for <$1/dose.

https://t.co/FOLOqlOgNb

@RyanM_Thomas

[Eyam Health @EyamHealth]

Mpox is surging again! At Eyam, we’re combating the outbreak with our AI-driven Jennerator platform and self-amplifying vaccines. Our goal? Rapid, effective, and accessible solutions for all .
👉 https://t.co/dh84QZ3gEL

#Mpox #Vaccines #Biotech #PandemicPreparedness #Innovation

[Eyam Health @EyamHealth]

Eyam announces the appointment of Wolfgang Koester to the Board, one of the “100 Most Influential People in Finance”. CEO, Ryan Thomas, said, “Wolfgang brings a proven track record of global business development at a time when Eyam is ramping up its partnering relationships."

[Eyam Health @EyamHealth]

Dive into the research and let's stay vigilant in our pursuit of knowledge. (5/5)
https://t.co/ZK0kbhylUw
#COVID19 #DeerStudy #ResearchMatters #StayInformed

[Eyam Health @EyamHealth]

SARS-CoV-2 in Deer: A Cause for Concern?

Researchers at Ohio State University have uncovered fascinating insights into the presence of SARS-CoV-2 in white-tailed deer. (1/5)

[Eyam Health @EyamHealth]

Despite a decrease in detections by the CDC and USDA APHIS, the persistence of divergent strains in deer, such as the Alpha variant, poses a new challenge. Understanding these dynamics is crucial to our ongoing battle against the virus. (4/5)

[Eyam Health @EyamHealth]

Dive into our latest newsletter with CEO @RyanM_Thomas on pandemic preparedness and the rise of Eris (EG.5). Explore insights into EG.5, its challenges, and the scientific frontlines of our ongoing battle. #PandemicPreparedness #ErisEG5 #COVID19
https://t.co/JlOkHLxKdh

[Eyam Health @EyamHealth]

Read more about this issue and let's all stay cautious and informed. (4/4)
#COVID19 #PublicHealth #StayInformed

https://t.co/GrV7OTpTPc

[Eyam Health @EyamHealth]

As winter approaches, COVID-19 cases are on the rise in the Northern Hemisphere, raising alarms at the WHO. Dr. Maria Van Kerkhove, WHO's technical lead on COVID-19, has urged countries to strengthen surveillance and reporting. (1/4)

[Eyam Health @EyamHealth]

We're also keeping a close eye on the highly mutated variant BA.2.86, a new twist in the pandemic.

As we move forward, it's vital to remember that the virus is still evolving, and governments must remain vigilant. (3/4)

[Eyam Health @EyamHealth]

Find us next week in-person at the @iambiotech BIO International Convention. As the largest gathering of the global #biotech community, we look forward to meeting with potential new partners. More info here: https://t.co/AUuDKmCh4e or meet with us: [email protected].

[Eyam Health @EyamHealth]

#eyamdailynewsblast

Researchers discover sex-specific genes, molecular pathways that contribute to #alzheimer's disease progression: https://t.co/3c0FTsqqdq

[Eyam Health @EyamHealth]

#eyamdailynewsblast

Study finds significant amount of clotting in the arteries of patients with #STEMI and #covid19: https://t.co/2jCluUBDXu

[Eyam Health @EyamHealth]

We are attending the @iambiotech International Convention in Boston on June 5-8. To meet with Eyam CEO Ryan M. Thomas and Director of Business Development Pamela Lincez, book a 1on1 spot here: [email protected].

https://t.co/UP2KhR1pwI

#standupforscience #bio2023

[Eyam Health @EyamHealth]

In collaboration with @mitacscanada, Eyam is founding a new #AI research facility for our #jennerator #bioinformatics platform. We will continue to leverage AI to anticipate new threats and reduce the time to design protective vaccines for both humans and animals.

[Eyam Health @EyamHealth]

#eyamdailynewsblast

New #CRISPR genome-editing technology helps scientists to explore many cancer-linked mutations: https://t.co/dWvfcFJJWn

[Eyam Health @EyamHealth]

Eyam CEO Ryan M. Thomas reflects on the importance of #animalvaccines in preventing the spread of #zoonoticdiseases - and how Eyam's latest platform can be used to develop #vaccines for a wide range of #animalspecies. Read the article: https://t.co/lN3aQNILZT